AGP Executive Report
Last update: 5 hours agoCOVID-19 & Flu Watch: Hong Kong’s Centre for Health Protection says COVID-19 activity is rising again (one-year high) alongside seasonal influenza, urging strict personal and environmental hygiene and mask use for high-risk groups. Weight-loss Drugs in Focus: A Mainland China study looks at what drives acceptance of weight-loss drugs among overweight and obese adults, as obesity remains a major health concern. Macau Health Policy: Macau’s Health Bureau expands hepatitis B screening and follow-up, monitoring about 23,000 patients and targeting older residents as liver cancer risk stays high. Tobacco Control: Macau lawmakers back amendments to tighten e-cigarette rules and expand smoke-free areas, including around hospital and school entrances, with higher penalties for illegal emerging tobacco products. Wellness & Community: The 2026 Guangdong & Macao Branded Products Fair (6–9 Aug, Cotai Expo) spotlights “silver economy” and healthy living, with wellness product showcases and business matching. Local Health Infrastructure: Macau’s Productivity and Technology Transfer Centre marks 30 years, pushing digital transformation and certification support tied to health supplements and proprietary Chinese medicines. Gongbei Border Seizure: Zhuhai customs seized 600 weight-loss injection vials (tirzepatide) at the ZHMB checkpoint, warning against unregistered imports.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.